BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38681062)

  • 1. Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma.
    Lv L; Zhang X; Liu Y; Zhu X; Pan R; Huang L
    Pharmgenomics Pers Med; 2024; 17():171-181. PubMed ID: 38681062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative multi-omics analysis based on liquid-liquid phase separation delineates distinct subtypes of lower-grade glioma and identifies a prognostic signature.
    Zheng J; Wu Z; Qiu Y; Wang X; Jiang X
    J Transl Med; 2022 Jan; 20(1):55. PubMed ID: 35093128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns.
    Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel model based on liquid-liquid phase separation-Related genes correlates immune microenvironment profiles and predicts prognosis of lung squamous cell carcinoma.
    Zhuge L; Zhang K; Zhang Z; Guo W; Li Y; Bao Q
    J Clin Lab Anal; 2022 Jan; 36(1):e24135. PubMed ID: 34799879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
    Zhou Q; Yan X; Liu W; Yin W; Xu H; Cheng D; Jiang X; Ren C
    Front Oncol; 2020; 10():586019. PubMed ID: 33425739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrated Bioinformatics Analysis to Identify a Novel Four-Gene Prognostic Model of Breast Cancer and Reveal Its Association with Immune Infiltration.
    Zhu Y; Luo J; Yang Y
    Crit Rev Immunol; 2024; 44(2):1-14. PubMed ID: 38305332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The study of an anoikis-related signature to predict glioma prognosis and immune infiltration.
    Zhang D; Wang Y; Zhou H; Han X; Hou L; Lv Z; Xue X
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):12659-12676. PubMed ID: 37450027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
    Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
    Front Genet; 2022; 13():1085700. PubMed ID: 36579330
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PANoptosis-related signature indicates the prognosis and tumor immune infiltration features of gliomas.
    Song J; Xu Z; Fan Q; Sun Y; Lin X
    Front Mol Neurosci; 2023; 16():1198713. PubMed ID: 37501725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
    Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
    Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
    [No Abstract]   [Full Text] [Related]  

  • 16. Illustrating the biological functions and diagnostic value of transmembrane protein family members in glioma.
    Zhang Y; Zhang W; Yuan Q; Hong W; Yin P; Shen T; Fang L; Jiang J; Shi F; Chen W
    Front Oncol; 2023; 13():1145676. PubMed ID: 37064154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer.
    Qiu Y; Pan M; Chen X
    Front Oncol; 2021; 11():671892. PubMed ID: 34168991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of molecular subtypes based on liquid-liquid phase separation and cross-talk with immunological phenotype in bladder cancer.
    Sun L; Liu XP; Yan X; Wu S; Tang X; Chen C; Li G; Hu H; Wang D; Li S
    Front Immunol; 2022; 13():1059568. PubMed ID: 36518754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
    Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.